ImCheck Therapeutics is a startup based in France, most recent round Acquired, 4 tracked investors.
ImCheck Therapeutics is a startup founded in 2016 based in France. ImCheck Therapeutics has been acquired. Brouky records 4 investors associated with the company.
ImCheck Therapeutics develops immunotherapeutic antibodies targeting butyrophilin and related checkpoint molecules to treat cancer, infectious diseases, and autoimmune disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.